Long-Term Low Dose Treatment With Pegylated Interferon Alpha 2b Leads To A Significant Reduction In Fibrosis And Inflammatory Score In Chronic Hepatitis C Nonresponder Patients With Fibrosis Or Cirrhosis
HEPATOLOGY（2007）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要